Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update
— Third quarter 2025 total revenue of approximately $69.5 million, including record net product sales of $64.1 million and contract revenues from collaborations of $5.4 million — Generated $27.9 million of net income in the third quarter of 2025 — Completed enrollment in the dose escalation phase and enrolled the first patient in the dose […]